health pharma news today obesity drugs glp-1 Could weight-loss eat the world? WHO scientists endorse weight loss

One case report describes the onset of dysphagia and gastroparesis in a patient with Crohns disease 2 months before developing Wernicke encephalopathy, which resolved with high dose thiamine (72)

The closer proximity to the insertion point directs peptide toward the affected area

In obese (OB/OB) mice, GLP-1 reduces ER stress in adipose tissue, improving insulin sensitivity through unresolved mechanisms (Yi et al., 2023)

However, this chemical process includes complex reaction processes and low yield, resulting in high cost and low purity of -EC, limiting the production of -EC for physical function investigations and medical/pharmaceutical applications

The development of effective vaccines for treating TNBC is anticipated to improve disease management